Drug Repurposing
Using a graph-based knowledge layer to connect fragmented R&D data and support drug repurposing decisions.
Data requirements
- Pre-clinical data — Named as part of the connected workflow context.
- Regulatory workflow data — Named as part of the connected workflow context.
- R&D knowledge — The graph ecosystem connects fragmented R&D knowledge across the process.
AI methods and techniques
- GraphRAG — Used to retrieve context from the connected knowledge graph.
- Agentic AI — Used on top of the graph ecosystem to support use cases such as drug repurposing.
- Knowledge graph modeling — Used to connect fragmented R&D data across workflows.
- MCP — Used to connect agents with the data and tools in the environment.
Industries
Real-world evidence
1 documented case study on record.
Companies using this: Merck Group.
View the full profile with evidence, implementation detail, and comparison tools
Explore full use case →
Explore full use case →